266 related articles for article (PubMed ID: 33535429)
41. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing].
Li YJ; Cao DY; Chen SZ
Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150
[TBL] [Abstract][Full Text] [Related]
42. Secretion of plasminogen activator inhibitor by normal rat pleural leukocytes in culture.
Li XY; Brown GM; Lamb D; Donaldson K
Lung; 1990; 168(6):309-22. PubMed ID: 2126320
[TBL] [Abstract][Full Text] [Related]
43. The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.
Sato J; Schorey J; Ploplis VA; Haalboom E; Krahule L; Castellino FJ
Am J Pathol; 2003 Aug; 163(2):517-31. PubMed ID: 12875972
[TBL] [Abstract][Full Text] [Related]
44. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
[No Abstract] [Full Text] [Related]
45. Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn2+ mediates strong and specific interaction of single-chain urokinase with fibrin.
Husain SS
J Biol Chem; 1993 Apr; 268(12):8574-9. PubMed ID: 8473303
[TBL] [Abstract][Full Text] [Related]
46. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
47. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
[TBL] [Abstract][Full Text] [Related]
48. Dysregulated fibrinolysis and plasmin activation promote the pathogenesis of osteoarthritis.
Wang Q; Shao G; Zhao X; Wong HH; Chin K; Zhao M; Bai A; Bloom MS; Love ZZ; Chu CR; Cheng Z; Robinson WH
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38502232
[TBL] [Abstract][Full Text] [Related]
49. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
Shanmukhappa K; Sabla GE; Degen JL; Bezerra JA
BMC Gastroenterol; 2006 Nov; 6():40. PubMed ID: 17134505
[TBL] [Abstract][Full Text] [Related]
50. Secretion of fibrinolytic enzymes facilitates human mesenchymal stem cell invasion into fibrin clots.
Neuss S; Schneider RK; Tietze L; Knüchel R; Jahnen-Dechent W
Cells Tissues Organs; 2010; 191(1):36-46. PubMed ID: 19390164
[TBL] [Abstract][Full Text] [Related]
51. Urokinase-type plasminogen activator (uPA) promotes ezrin-mediated reorganization of the synaptic cytoskeleton in the ischemic brain.
Merino P; Diaz A; Manrique LG; Cheng L; Yepes M
J Biol Chem; 2018 Jun; 293(24):9234-9247. PubMed ID: 29720403
[TBL] [Abstract][Full Text] [Related]
52. Disordered pathways of fibrin turnover in lung lavage of premature infants with respiratory distress syndrome.
Viscardi RM; Broderick K; Sun CC; Yale-Loehr AJ; Hessamfar A; Taciak V; Burke KC; Koenig KB; Idell S
Am Rev Respir Dis; 1992 Aug; 146(2):492-9. PubMed ID: 1489146
[TBL] [Abstract][Full Text] [Related]
53. Leukocyte urokinase plasminogen activator receptor and PSGL1 play a role in endogenous arterial fibrinolysis.
Bai X; Weitz JI; Gross PL
Thromb Haemost; 2009 Dec; 102(6):1212-8. PubMed ID: 19967153
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiology of the plasminogen/plasmin system.
Lijnen HR
Int J Clin Lab Res; 1996; 26(1):1-6. PubMed ID: 8739849
[TBL] [Abstract][Full Text] [Related]
55. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.
Swaisgood CM; French EL; Noga C; Simon RH; Ploplis VA
Am J Pathol; 2000 Jul; 157(1):177-87. PubMed ID: 10880388
[TBL] [Abstract][Full Text] [Related]
56. Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.
Mahmood N; Rabbani SA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33921923
[TBL] [Abstract][Full Text] [Related]
57. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
Van Leer C; Stutz M; Haeberli A; Geiser T
Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
[TBL] [Abstract][Full Text] [Related]
58. Single-chain urokinase in empyema induced by Pasturella multocida.
Idell S; Jun Na M; Liao H; Gazar AE; Drake W; Lane KB; Koenig K; Komissarov A; Tucker T; Light RW
Exp Lung Res; 2009 Oct; 35(8):665-81. PubMed ID: 19895321
[TBL] [Abstract][Full Text] [Related]
59. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
60. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
